Stocks in play: Aurora Cannabis Inc
Said its Aurora Europe GmbH subsidiary and Ethypharm have once again been selected by the French General Directorate of Health as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently been extended until March 2024. Aurora Cannabis Inc shares T.ACB are trading up $0.01 at $0.74.
Read:
Promising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting
Global Lithium Supply Under Pressure as South American Nations Discuss "Lithium OPEC"
International Lithium Buyers Looking to South America to Fill Supply Gaps
Race to Secure Critical EV Battery Metals Ahead of Chinese Dominance Fully Underway
Help is on the Way as Rising Alzheimer’s Cases Highlight Urgency for New Treatments